申请人:Merck Patent Gesellschaft mit beschrankter Haftung
公开号:US04051173A1
公开(公告)日:1977-09-27
Phenoxylakanols of the formula ##STR1## wherein R.sup.1 is H or CH.sub.3 ; R.sup.2 is CH.sub.3 or C.sub.6 H.sub.5 ; R.sup.3 is 4-Hal-phenoxymethyl, 1,2,3,4-tetrahydro-1-naphthyl, 1-pyrryl, piperidino, isoindoline, 1,2,3,4-tetrahydroquinoline, 1,2,3,4-tetrahydro-1-R.sup.5 -4-quinolyl, 4-chromanyl, 4-thiochromanyl, or, when at least one of R.sup.1 and R.sup.2 is other than CH.sub.3, also Hal, phenyl, 4-Hal-phenyl or 4-Hal-phenoxy, wherein R.sup.4 is H or alkanoyl of 2-4 carbon atoms, R.sup.5 is H or CH.sub.3 and Hal if F, Cl or Br; and physiologically acceptable acid addition salts thereof possess pharmacological activity, particularly cholesterol, triglyceride and uric acid blood-level lowering activity and are also useful as intermediates for the production of the corresponding phenoxyacetic acids.
化学式为 ##STR1## 的Phenoxylakanols,其中R.sup.1为H或CH.sub.3; R.sup.2为CH.sub.3或C.sub.6H.sub.5; R.sup.3为4-Hal-phenoxymethyl,1,2,3,4-tetrahydro-1-naphthyl,1-pyrryl,piperidino,isoindoline,1,2,3,4-tetrahydroquinoline,1,2,3,4-tetrahydro-1-R.sup.5-4-quinolyl,4-chromanyl,4-thiochromanyl,或者当R.sup.1和R.sup.2中至少有一个不是CH.sub.3时,也可以是Hal,苯基,4-Hal-苯基或4-Hal-苯氧基,其中R.sup.4为H或2-4碳原子的脂肪酰基,R.sup.5为H或CH.sub.3,如果F,Cl或Br,则为Hal。其生理学上可接受的酸盐具有药理活性,特别是降低胆固醇、甘油三酯和尿酸血液水平的活性,并且还可用作生产相应的苯氧乙酸的中间体。